Historical record - last NADAC effective date: 12/20/2023
Product Information
TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.1199 per EA under NDC 68001038803. Its NADAC has been published 216 times since Nov 13, 2019.
FDA first approved this application on Nov 30, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 75 mg/1; mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001038803
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
12/20/2023
Active Ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA071851FDA Approved
11/30/1988
TE Code
AB
On Market Since
6/18/2019
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB has been published 216 times since Nov 13, 2019, and over the history we have for it it has declined 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1199 per EA |
|---|---|
| All-time high | $0.1476 (Nov 13, 2019) |
| All-time low | $0.1150 (Oct 18, 2023) |
| Median price | $0.1301 |
| Average price | $0.1284 |
| Largest weekly change | +14.3% (Aug 23, 2023) |
| Weeks tracked | 216 |
| Tracking since | Nov 13, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+3.1%
5Y
-12.8%
All
-18.8%
Last surveyed Dec 27, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB, manufactured by BluePoint Laboratories, is $0.1199 per EA (NDC 68001038803), effective Dec 27, 2023.
How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB has declined 18.8%. It has been tracked across 216 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?
Since Nov 13, 2019, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB has ranged from a low of $0.1150 (Oct 18, 2023) to a high of $0.1476 (Nov 13, 2019), with a median of $0.1301 per EA.
Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?
TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB (NDC 68001038803) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.